INCOME TAXES	9 Months Ended
Jan. 30, 2016
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES At May 2, 2015, we recorded a deferred tax benefit of $7.2 million related to the release of a foreign valuation allowance and a $1.4 million deferred tax benefit related to the release of our state valuation allowance. The Company evaluated all available positive and negative evidence, including past operating results and projection of future taxable income and determined it is more likely than not that expected future taxable income will be sufficient to utilize substantially all of our foreign, federal and U.S. state net deferred tax assets. The Company maintained a valuation allowance of $1.2 million at January 30, 2016 and May 2, 2015 related to certain state and federal net operating loss carryovers and expects to continue to maintain this allowance until we determine that these deferred tax assets are more likely than not realizable. At January 30, 2016, we had available $2.1 million of federal and $80.6 million of state net operating loss carry forwards (having a tax benefit of $0.7 million and $3.8 million, respectively) and $4.3 million of foreign tax credit carry forwards, and a $0.5 million research expenditure credit carry-forward. If unused, the U.S. federal net operating loss carry forwards will expire in the fiscal years 2018 through 2031. The state net operating loss carry forwards will expire in the fiscal years 2016 through 2035. The foreign tax credits will expire in the fiscal years 2023 through 2024. The research expenditure credit will expire in fiscal year 2035. The tax laws of Malta provide for investment tax credits of 30% of qualified expenditures. Unused credits of $16.1 million as of January 30, 2016 can be carried forward indefinitely. We record investment tax credits using the "flow through" method. The Company recognized an income tax provision of $5.5 million and $8.1 million for the three months ended January 30, 2016 and January 31, 2015, respectively. The Company's effective tax rate was 24.1% and 23.0% for the three months ended January 30, 2016 and January 31, 2015, respectively. The Company recognized an income tax provision of $18.6 million and $23.8 million for the nine months ended January 30, 2016 and January 31, 2015, respectively. The Company's effective tax rate was 23.1% and 24.2% for the nine months ended January 30, 2016 and January 31, 2015, respectively. The income tax provision for both the three and nine months ended January 30, 2016 and January 31, 2015 is lower than the U.S. statutory rate primarily due to foreign investment tax credits and foreign operations with lower statutory rates. We record interest and penalties accrued related to the unrecognized tax benefits in the provision for income taxes. We had approximately $0.1 million accrued at January 30, 2016 for the payment of interest and penalties. The total unrecognized tax benefit as of January 30, 2016 was $0.9 million. We recorded an unrecognized tax benefit of $0.1 million in the first nine months of fiscal 2016. The Company and all of its domestic subsidiaries file income tax returns in the U.S. federal jurisdiction and various states. Our foreign subsidiaries file income tax returns in certain foreign jurisdictions since they have operations outside the U.S. The Company and its subsidiaries are generally no longer subject to U.S. federal, state and local examinations by tax authorities for all years except fiscal 2015, 2014, 2013, 2012 and 2011.

INCOME TAXES

At May 2, 2015, we recorded a deferred tax benefit of $7.2 million related to the release of a foreign valuation allowance and a $1.4 million deferred tax benefit related to the release of our state valuation allowance. The Company evaluated all available positive and negative evidence, including past operating results and projection of future taxable income and determined it is more likely than not that expected future taxable income will be sufficient to utilize substantially all of our foreign, federal and U.S. state net deferred tax assets. The Company maintained a valuation allowance of $1.2 million at January 30, 2016 and May 2, 2015 related to certain state and federal net operating loss carryovers and expects to continue to maintain this allowance until we determine that these deferred tax assets are more likely than not realizable.

At January 30, 2016, we had available $2.1 million of federal and $80.6 million of state net operating loss carry forwards (having a tax benefit of $0.7 million and $3.8 million, respectively) and $4.3 million of foreign tax credit carry forwards, and a $0.5 million research expenditure credit carry-forward. If unused, the U.S. federal net operating loss carry forwards will expire in the fiscal years 2018 through 2031. The state net operating loss carry forwards will expire in the fiscal years 2016 through 2035. The foreign tax credits will expire in the fiscal years 2023 through 2024. The research expenditure credit will expire in fiscal year 2035.

The tax laws of Malta provide for investment tax credits of 30% of qualified expenditures. Unused credits of $16.1 million as of January 30, 2016 can be carried forward indefinitely. We record investment tax credits using the "flow through" method.

The Company recognized an income tax provision of $5.5 million and $8.1 million for the three months ended January 30, 2016 and January 31, 2015, respectively. The Company's effective tax rate was 24.1% and 23.0% for the three months ended January 30, 2016 and January 31, 2015, respectively. The Company recognized an income tax provision of $18.6 million and $23.8 million for the nine months ended January 30, 2016 and January 31, 2015, respectively. The Company's effective tax rate was 23.1% and 24.2% for the nine months ended January 30, 2016 and January 31, 2015, respectively. The income tax provision for both the three and nine months ended January 30, 2016 and January 31, 2015 is lower than the U.S. statutory rate primarily due to foreign investment tax credits and foreign operations with lower statutory rates.

We record interest and penalties accrued related to the unrecognized tax benefits in the provision for income taxes. We had approximately $0.1 million accrued at January 30, 2016 for the payment of interest and penalties. The total unrecognized tax benefit as of January 30, 2016 was $0.9 million. We recorded an unrecognized tax benefit of $0.1 million in the first nine months of fiscal 2016.

The Company and all of its domestic subsidiaries file income tax returns in the U.S. federal jurisdiction and various states. Our foreign subsidiaries file income tax returns in certain foreign jurisdictions since they have operations outside the U.S. The Company and its subsidiaries are generally no longer subject to U.S. federal, state and local examinations by tax authorities for all years except fiscal 2015, 2014, 2013, 2012 and 2011.